Companion Medical

2020: Medtronic purchased Companion Medical

In the middle of August, 2020 Medtronic announced acquisition of the producer insulin the syringe handles Companion Medical for the unsolved amount. The product portfolio of Companion Medical includes intellectual insulin the syringe handle InPen which is combined with the application for management of diabetes. The application allows to calculate insulin doses, keeps track of activity of insulin and sends reports to doctors. In the USA these means are available only according to the recipe. InPen supplements the portfolio of Medtronic for diabetics including an insulin pump of MiniMed, the Guardian CGM system and others.

Medtronic purchased Companion Medical

We wait for an opportunity to develop success of InPen, having integrated it with our intellectual algorithms for individual recommendations about dosing. The intelligent system of CGM allows patients not to think of problems of diabetes and to live on own conditions, - the executive vice president and the president of group of diabetes of Medtronic Sean Salmon noted. - Our purpose - to become the reliable partner who offers continued support to all patients who use different techniques of introduction of insulin.

Acquisition of Companion Medical supplements recent strategic purchases of Medtronic which will help to develop powerful algorithms for deep data analysis and to develop possibilities of artificial intelligence. Thanks to this acquisition Medtronic is going to advance further automation of data analysis and calculation of a dosage. The CEO and the cofounder of Companion Medical Sean of Saint (Sean Saint) calculates that Medtronic will be able to provide access to InPen to patients around the world. It is expected that the transaction will be closed within one-two months. Completion of the transaction will depend on accomplishment of certain obligations and approval of regulatory bodies.^[1]

Notes